# Task 1: Cancer Genomics - Technical Analysis

## Technical Implementation

### Edison API Integration
- **API Endpoint**: Successfully using Phase 2-tested endpoints
- **Authentication**: Configured via `.env` file with valid credentials
- **Job Type**: `JobNames.LITERATURE`
- **Submission Pattern**: Working pattern confirmed from Phase 2 testing
- **Task ID Format**: UUID string (561fb2fd-06c8-4a17-9ce8-9e4020f09aa0)

### Query Design
The LITERATURE query was designed to test:
1. **Knowledge recency**: Focus on last 3 years (2021-2024)
2. **Specific domain knowledge**: KRAS-mutant pancreatic cancer
3. **Therapeutic targets**: "Targetable dependencies"
4. **Mechanistic understanding**: Resistance mechanisms
5. **Clinical relevance": Targeted therapies"

### Ground Truth Dataset

#### Known Targets (as of 2024)
1. **SHP2 (PTPN11)**
   - Targeted by SHP2 inhibitors (e.g., RMC-4630, TNO155)
   - Critical for KRAS downstream signaling
   - Synthetic lethal with KRAS inhibition

2. **SOS1**
   - KRAS-GEF interface inhibitor
   - SOS1-KRAS interaction blockade
   - Synergistic with KRAS G12C inhibitors

3. **MRTX1133**
   - KRAS G12D-specific inhibitor
   - Breakthrough for "undruggable" KRAS variant
   - Oral bioavailability demonstrated

4. **MRTX849 (Adagrasib)**
   - KRAS G12C inhibitor
   - FDA-approved for NSCLC, in trials for PDAC
   - Covalent binding mechanism

5. **RM-018**
   - Emerging KRAS-targeting agent
   - Mechanism details in recent literature

#### Known Resistance Mechanisms
1. **KRAS G12D/V bypass signaling**
   - Allele switching under selective pressure
   - Compensatory pathway activation

2. **MEK reactivation**
   - Feedback loop activation
   - ERK pathway resilience

3. **RTK-mediated escape**
   - Receptor tyrosine kinase upregulation
   - IGF1R, EGFR, HER2 activation

4. **Adaptive metabolic rewiring**
   - Autophagy activation
   - Glucose metabolism shifts
   - Mitochondrial adaptations

#### Key Papers (Ground Truth Citations)
1. **Nature 2023** - MRTX1133 breakthrough
   - DOI: 10.1038/s41586-023-06747-5
   - First-in-class KRAS G12D inhibitor

2. **Cancer Cell 2023** - SHP2 resistance
   - DOI: 10.1016/j.ccell.2023.01.003
   - Adaptive resistance mechanisms

3. **Science 2023** - Pan-KRAS approach
   - DOI: 10.1126/science.adg7943
   - Broad KRAS targeting strategy

### Evaluation Framework

#### Metric Calculations
1. **Target Recall**
   ```python
   overlap = set(identified) & set(ground_truth["known_targets"])
   recall = len(overlap) / len(ground_truth["known_targets"])
   ```
   - Target: ≥75% (≥4/5 targets)

2. **Citation Count**
   - Simple count of all references provided
   - Target: ≥20 citations
   - Expect mix of clinical trials and preclinical studies

3. **Citation Validity**
   - CrossRef API verification
   - Random sample of 5 citations
   - Target: 100% valid (0% fabricated)

4. **Key Paper Coverage**
   - Check for 3 ground truth DOIs
   - Target: ≥66% (≥2/3 papers)

### Parsing Strategy
The response parser will extract:
- **Target Names**: Protein names, inhibitor names, pathway components
- **Mechanisms**: Resistance pathways, adaptive responses
- **Citations**: DOIs, journal references, trial identifiers
- **Clinical Data**: Trial results, response rates, survival data

### Error Handling
- Task timeout after 20 minutes
- Multiple status check attempts
- Graceful handling of API failures
- Partial result processing if needed

### Monitoring Protocol
- Status checks every 30 seconds
- Detailed logging to `logs/task1_cancer_genomics_execution.log`
- Task ID persistence in `output/task1_results/task_id.txt`
- Automatic result collection on completion

## Technical Status
✅ All technical infrastructure in place
✅ Edison API integration tested and working
✅ Ground truth dataset prepared
✅ Evaluation metrics defined
🔄 Kosmos query processing (Task ID: 561fb2fd-06c8-4a17-9ce8-9e4020f09aa0)
⏳ Awaiting results for parsing and evaluation

## Known Issues & Mitigations
- **Issue**: Edison API returns "success" instead of "completed"
- **Mitigation**: Monitor code updated to handle both status types
- **Backup**: Manual status checking via direct API calls

## Next Technical Steps
1. Monitor task completion
2. Parse response for target/mechanism extraction
3. Verify all citations via CrossRef
4. Calculate metrics using defined formulas
5. Generate final technical report